ISSN:

Journal Home

Molecular Neurodegeneration Q1 Unclaimed

BioMed Central Ltd. United Kingdom

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Molecular Neurodegeneration is a journal indexed in SJR in Molecular Biology and Neurology (clinical) with an H index of 83. It is an CC BY Journal with a Single blind Peer Review review system, and It has a price of 1815 €. The scope of the journal is focused on neurodegenerative diseases, prion diseases, dementia, ageing. It has an SJR impact factor of 5,565 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 5,565.

Type: Journal

Type of Copyright: CC BY

Languages: English

Open Access Policy: Open Access

Type of publications:

Publication frecuency: -

Categories: Cellular and Molecular Neuroscience (Q1) Molecular Biology (Q1) Neurology (clinical) (Q1)

Price

1815 €

Inmediate OA

NPD

Embargoed OA

- €

Non OA

Metrics

5,565

SJR Impact factor

83

H Index

64

Total Docs (Last Year)

206

Total Docs (3 years)

6059

Total Refs

2523

Total Cites (3 years)

206

Citable Docs (3 years)

12,52

Cites/Doc (2 years)

94,67

Ref/Doc

Other journals with similar parameters

Nature Structural and Molecular Biology Q1
Molecular Systems Biology Q1
Cell Host and Microbe Q1
EMBO Journal Q1
Nature Protocols Q1

Compare this journals

Aims and Scope

Neurodegenerative diseases Prion diseases Dementia Ageing

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .